466 related articles for article (PubMed ID: 31790497)
21. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's sarcoma-associated herpesvirus: the role of lytic replication in targeted therapy.
Andrei G; Snoeck R
Curr Opin Infect Dis; 2015 Dec; 28(6):611-24. PubMed ID: 26524334
[TBL] [Abstract][Full Text] [Related]
23. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.
Medveczky MM; Horvath E; Lund T; Medveczky PG
AIDS; 1997 Sep; 11(11):1327-32. PubMed ID: 9302441
[TBL] [Abstract][Full Text] [Related]
24. NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latency.
Ma Z; Hopcraft SE; Yang F; Petrucelli A; Guo H; Ting JP; Dittmer DP; Damania B
PLoS Pathog; 2017 May; 13(5):e1006350. PubMed ID: 28459883
[TBL] [Abstract][Full Text] [Related]
25.
Kang SK; Kang YH; Yoo SM; Park C; Kim HS; Lee MS
J Virol; 2021 Jul; 95(16):e0079921. PubMed ID: 34105998
[TBL] [Abstract][Full Text] [Related]
26. CRISPR/Cas9-Mediated Knockout and
BeltCappellino A; Majerciak V; Lobanov A; Lack J; Cam M; Zheng ZM
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413125
[TBL] [Abstract][Full Text] [Related]
27. Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency.
Ye F; Zhou F; Bedolla RG; Jones T; Lei X; Kang T; Guadalupe M; Gao SJ
PLoS Pathog; 2011 May; 7(5):e1002054. PubMed ID: 21625536
[TBL] [Abstract][Full Text] [Related]
28. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
Watanabe T; Fujimuro M
Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
[TBL] [Abstract][Full Text] [Related]
29. Pemetrexed inhibits Kaposi's sarcoma-associated herpesvirus replication through blocking dTMP synthesis.
Chen J; Zhang H; Chen X
Antiviral Res; 2020 Aug; 180():104825. PubMed ID: 32461120
[TBL] [Abstract][Full Text] [Related]
30. Chloroquine inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by disrupting mTOR and p38-MAPK activation.
Yang M; Huang L; Li X; Kuang E
Antiviral Res; 2016 Sep; 133():223-33. PubMed ID: 27521848
[TBL] [Abstract][Full Text] [Related]
31. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.
Whitby D; Marshall VA; Bagni RK; Miley WJ; McCloud TG; Hines-Boykin R; Goedert JJ; Conde BA; Nagashima K; Mikovits J; Dittmer DP; Newman DJ
Int J Cancer; 2007 Jan; 120(2):321-8. PubMed ID: 17066452
[TBL] [Abstract][Full Text] [Related]
32. Celecoxib Inhibits the Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK.
Chen J; Jiang L; Lan K; Chen X
Viruses; 2015 May; 7(5):2268-87. PubMed ID: 25951487
[TBL] [Abstract][Full Text] [Related]
33. Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway.
Li S; Hu H; He Z; Liang D; Sun R; Lan K
PLoS Pathog; 2016 Oct; 12(10):e1005900. PubMed ID: 27760204
[TBL] [Abstract][Full Text] [Related]
34. Minimal reactivation of Kaposi's sarcoma-associated herpesvirus by corticosteroids in latently infected B cell lines.
Zoeteweij JP; Rinderknecht AS; Davis DA; Yarchoan R; Blauvelt A
J Med Virol; 2002 Mar; 66(3):378-83. PubMed ID: 11793390
[TBL] [Abstract][Full Text] [Related]
35. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.
Xie J; Ajibade AO; Ye F; Kuhne K; Gao SJ
Virology; 2008 Feb; 371(1):139-54. PubMed ID: 17964626
[TBL] [Abstract][Full Text] [Related]
36. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
[TBL] [Abstract][Full Text] [Related]
37. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
38. Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1.
Qin D; Feng N; Fan W; Ma X; Yan Q; Lv Z; Zeng Y; Zhu J; Lu C
BMC Microbiol; 2011 Oct; 11():240. PubMed ID: 22032493
[TBL] [Abstract][Full Text] [Related]
39. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.
Li D; Mosbruger T; Verma D; Swaminathan S
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380
[TBL] [Abstract][Full Text] [Related]
40. Development of an ORF45-Derived Peptide To Inhibit the Sustained RSK Activation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
Li X; Huang L; Xiao Y; Yao X; Long X; Zhu F; Kuang E
J Virol; 2019 May; 93(10):. PubMed ID: 30842327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
